Jolliffe, D. A., Camargo, C. A., Sluyter, J. D., Aglipay, M., Aloia, J. F., Bergman, P., Bischoff-Ferrari, H. A., Borzutzky, A., Bubes, V. Y., Damsgaard, C. T., Ducharme, F. M., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Gilham, C., Ginde, A. A., Golan-Tripto, I., Goodall, E. C., Grant, C. C., … Martineau, A. R. (2025). Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(24)00348-6

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., le Roux, C. W., Sattar, N., Baur, L. A., Morrison, K. M., Misra, A., Kadowaki, T., Tham, K. W., Sumithran, P., Garvey, W. T., … Mingrone, G. (2025). Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(24)00316-4

Argente, J., Verge, C. F., Okorie, U., Fennoy, I., Kelsey, M. M., Cokkinias, C., Scimia, C., Lee, H.-M., & Farooqi, I. S. (2024). Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(24)00273-0

van Sloten, T. T., Luchsinger, J. A., Launer, L. J., Strachan, M., Cukierman-Yaffe, T., Gerstein, H. C., Sattar, N., & Biessels, G. J. (2024). Call for effective therapies for preventing dementia in people with type 2 diabetes. The Lancet Diabetes & Endocrinology, 12(8), 510–513. https://doi.org/10.1016/s2213-8587(24)00158-x

Schwartz, A. V., Backlund, J.-Y. C., de Boer, I. H., Rubin, M. R., Barnie, A., Farrell, K., Trapani, V. R., Gregory, N. S., Wallia, A., Bebu, I., Lachin, J. M., Braffett, B. H., & Gubitosi-Klug, R. (2022). Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study. The Lancet Diabetes & Endocrinology, 10(7), 509–518. https://doi.org/10.1016/s2213-8587(22)00103-6

Raverdy, V., Cohen, R. V., Caiazzo, R., Verkindt, H., Petry, T. B. Z., Marciniak, C., Legendre, B., Bauvin, P., Chatelain, E., Duhamel, A., Drumez, E., Oukhouya-Daoud, N., Chetboun, M., Baud, G., Ahlqvist, E., Wierup, N., Asplund, O., Laferrère, B., Groop, L., & Pattou, F. (2022). Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study. The Lancet Diabetes & Endocrinology, 10(3), 167–176. https://doi.org/10.1016/s2213-8587(22)00005-5